Answers are grounded in this paper and cite their sources.
OR7C1 is a novel marker for colon CICs and can be a target of potent CIC-targeting immunotherapy. Clin Cancer Res; 22(13); 3298-309.
No takes yet. Share an insight, caveat, or question.
Morita et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: